help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, Y.-X.
Right arrow Articles by Segaloff, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, Y.-X.
Right arrow Articles by Segaloff, D. L.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 8 3936-3942
Copyright © 2004 by The Endocrine Society

Functional Characterization of Melanocortin-3 Receptor Variants Identify a Loss-of-Function Mutation Involving an Amino Acid Critical for G Protein-Coupled Receptor Activation

Ya-Xiong Tao and Deborah L. Segaloff

Department of Physiology and Biophysics, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242

Address all correspondence and requests for reprints to: Ya-Xiong Tao, Ph.D., Department of Physiology and Biophysics, 5-471 Bowen Science Building, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242. E-mail: ya-xiong-tao{at}uiowa.edu.

Although melanocortin-4 receptor mutations are the cause of the most common monogenic form of obesity, the involvement of the melanocortin-3 receptor (MC3R) in the pathogenesis of obesity is unknown. Earlier studies failed to identify any mutations in obese patients except for the identification of two variants (K6T and I81V) that likely represent polymorphisms. However, a potential mutation (I183N) was recently reported from patients having high-fat contents. We report here the functional characterization of these variants. We show that K6T and I81V have ligand binding and signaling properties similar to wild-type (wt) MC3R, indicating that they are indeed polymorphisms. However, the other variant, I183N, completely lacks signaling in response to agonist stimulation, although it binds ligand with normal affinity and with only slightly decreased capacity. Coexpression of the wt and I183N MC3Rs showed that I183N does not exert dominant-negative activity on wt MC3R. These results provide supporting evidence for the hypothesis proposed in the original case report that MC3R mutation might be a genetic factor that confers susceptibility to obesity, likely due to haploinsufficiency. Further mutations at I183 revealed a discrete requirement for I183 in agonist-induced MC3R activation. The corresponding residue is also important for agonist-induced human melanocortin-4 receptor and lutropin receptor activation. In summary, we identify a residue that is critical for activation of G protein-coupled receptors.

This work was supported by a Beginning-Grant-in-Aid (0265236Z) from the American Heart Association Heartland Affiliate (to Y.-X.T.) and National Institutes of Health Grant HD22196 (to D.L.S.).

Abbreviations: CG, Chorionic gonadotropin; GPCR, G proteincoupled receptor; h, human; LHR, human lutropin receptor; MCR, melanocortin receptor; MSH, melanocyte stimulating hormone; NDP-MSH, [Nle4,D-Phe7]-{alpha}MSH; NIDDM, non-insulin-dependent diabetes mellitus; POMC, proopiomelanocortin; TM, transmembrane; wt, wild-type.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. A. Calton, B. A. Ersoy, S. Zhang, J. P. Kane, M. J. Malloy, C. R. Pullinger, Y. Bromberg, L. A. Pennacchio, R. Dent, R. McPherson, et al.
Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study
Hum. Mol. Genet., March 15, 2009; 18(6): 1140 - 1147.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
Z.-C. Fan, J. L Sartin, and Y.-X. Tao
Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor
J. Endocrinol., January 1, 2008; 196(1): 139 - 148.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Seng Lee, L. Kok Seng Poh, B. Lay Kee Kek, and K. Yin Loke
The Role of Melanocortin 3 Receptor Gene in Childhood Obesity
Diabetes, October 1, 2007; 56(10): 2622 - 2630.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-X. Tao and D. L. Segaloff
Functional Analyses of Melanocortin-4 Receptor Mutations Identified from Patients with Binge Eating Disorder and Nonobese or Obese Subjects
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5632 - 5638.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Feng, S. F. Young, G. Aguilera, E. Puricelli, D. C. Adler-Wailes, N. G. Sebring, and J. A. Yanovski
Co-occurrence of Two Partially Inactivating Polymorphisms of MC3R Is Associated With Pediatric-Onset Obesity
Diabetes, September 1, 2005; 54(9): 2663 - 2667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society